A practical reference on 免疫调节: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-09-20 and is reviewed periodically as new material appears.
The name itself causes confusion, because several unrelated thymic peptides share the thymosin label. Thymosin beta-4, for example, is a different molecule with different functions. Naming conventions in the literature also mix descriptive research terms with assigned nonproprietary names, so a reader should confirm which entity a given paper addresses. Clarifying that point is usually the first step in interpreting any claim about this peptide.
Thymosin alpha-1 is a short peptide of 28 amino acid residues first described in the 1970s as a component of thymic extracts. Its N-terminal residue carries an acetyl group, and the sequence is highly conserved across mammalian species. The peptide is not encoded as a standalone gene product; it is released by proteolytic cleavage from the N-terminus of prothymosin alpha, a larger acidic nuclear protein. That precursor relationship places it within a broader family of thymic and immune-associated peptides that have been studied for decades.
Quantifying thymosin alpha-1 in a sample usually relies on reverse-phase high-performance liquid chromatography. The peptide lacks strong chromophores, so detection often occurs at 214 nm, where the peptide backbone absorbs. Mass spectrometry provides confirmatory identification and can detect sequence variants or truncations. Immunoassays have been used in biological matrices, but they may cross-react with related fragments. For purity assessment, chromatographic peak area gives the main component percentage, while mass accuracy verifies molecular identity.
The lyophilized peptide is generally stable for extended periods when kept cold and dry. Once dissolved, aqueous solutions are less stable; hydrolysis, oxidation, and aggregation can degrade the material. Storage at -20 °C or lower slows these processes. Repeated freeze-thaw cycles are best avoided because they can promote aggregation. The exact shelf life depends on formulation, pH, and concentration, so stability studies are typically performed for each specific product.
Quality control for thymosin alpha-1 focuses on identity, purity, and potency. Identity is confirmed by mass spectrometry and amino acid analysis, while purity is assessed by chromatography with limits on related substances and residual solvents. Potency assays may use cell-based immune readouts, but these are not standardized across laboratories. Regulatory status differs by jurisdiction; no product is approved in the United States for clinical use, whereas some other countries register injectable forms for specific indications.
| Property | Value | Notes |
|---|---|---|
| Residue count | 28 amino acids | Acetyl group on the first residue |
| Approximate molecular mass | 3108 daltons | Calculated from the consensus sequence |
| Origin | Cleavage product of prothymosin alpha | Not encoded as a separate gene product |
| Primary research focus | Immune modulation | Studied in viral hepatitis and as a vaccine adjuvant |
| Common synonyms | Thymalfasin, Tα1, thymosin alpha 1 | Thymalfasin is the assigned nonproprietary name |
在信号层面，Tα1可能通过Toll样受体等模式识别受体发挥作用。部分实验显示，它能激活髓样分化因子88依赖的通路，进而促进核因子κB进入细胞核。这导致白细胞介素2、干扰素γ和白细胞介素12等细胞因子的转录增加。这些细胞因子偏向辅助性T细胞1型应答，有助于细胞免疫。然而，具体受体和结合位点尚未完全确定，不同实验模型的结果存在差异。
临床研究将Tα1用于慢性病毒感染、肿瘤辅助治疗和疫苗佐剂等场景。部分试验报告了免疫学指标改善，但临床终点获益在不同研究中并不一致。系统综述指出，研究间在人群、剂量和联合方案上差异较大，难以汇总结论。因此，Tα1的确切临床地位仍属开放问题，需要更多高质量随机对照试验来澄清。其机制研究也需从体外实验向体内模型推进。
胸腺素α1对免疫系统的影响涉及多种细胞类型。研究表明，它可促进未成熟T细胞向成熟T细胞分化，并增强T细胞对抗原刺激的增殖反应。树突状细胞在Tα1存在下表达更高水平的共刺激分子，从而更有效地呈递抗原。此外，自然杀伤细胞的活性也观察到上升。这些效应并非直接杀伤病原体，而是调节宿主免疫应答的强度与方向。
Identity and purity are assessed with a small set of standard peptide methods. Reversed-phase high-performance liquid chromatography separates the main peak from truncated or oxidized species, and its area percentage is the usual purity measure. Mass spectrometry confirms the observed molecular mass against the expected value, while amino acid analysis or peptide mapping checks composition and sequence. Specifications for research-grade material are often stated as 95 percent or higher, though the exact limit depends on the supplier and the intended use.
Laboratory supplies of the peptide usually arrive as a lyophilized powder in sealed vials. The powder is hygroscopic, so a vial should be allowed to reach room temperature before it is opened to prevent condensation on the contents. Weighing and transfer are best performed in a low-humidity environment with clean tools. Once dissolved, the solution should be mixed gently rather than vortexed, because foaming and shear can reduce recovery of the peptide.
Storage recommendations center on low temperature, dryness, and protection from repeated freezing and thawing. The intact powder is commonly held at 20 degrees below zero Celsius or colder, while a working solution is divided into single-use aliquots to limit freeze-thaw cycles. Buffered saline or phosphate-buffered saline at neutral pH is frequently used as a diluent. Light sensitivity is not well documented, yet amber vials or foil wrapping are common practice for long-term storage of peptide stocks.
Bis(2-sulfanylethyl)amido group, also called SEA group, belongs to this family. Polypeptide C-terminal bis(2-sulfanylethyl)amides (SEA peptide segments) react with Cys peptide to give a native peptide bond as in NCL. This reaction, which is called SEA Native Peptide Ligation, is a useful variant of native chemical ligation. In making peptide segments that contain an N-terminal cysteine residue, exposure to ketones should be avoided since these may cap the N-terminal cysteine. Do not use protecting groups that release aldehydes or ketones. For the same reason, the use of acetone should be avoided, particularly in washing glassware used for lyophilization. A feature of the native chemical ligation technique is that the product polypeptide chain contains cysteine at the site of ligation. The cysteine at the ligation site can be desulfurized to alanine, thus extending the range of possible ligation sites to include alanine residues. Other beta-thiol containing amino acids can be used for native chemical ligation, followed by desulfurization. Alternatively, thiol-containing ligation auxiliaries can be used that mimic an N-terminal cysteine for the ligation reaction, but which can be removed after synthesis. The use of thiol-containing auxiliaries may not be as effective as ligation at a Cys residue. Native chemical ligation can also be performed with an N-terminal selenocysteine residue.
These complications of advanced atherosclerosis are chronic, slowly progressive, and cumulative. Most commonly, soft plaque suddenly ruptures (see vulnerable plaque), causing the formation of a thrombus that will rapidly slow or stop blood flow, leading to the death of the tissues fed by the artery in approximately five minutes. This event is called an infarction.
Dicyanamide (abbreviated as dca when a ligand) is an anion with the formula C2N−3. It contains two cyanide groups bound to a central nitrogen anion. Dicyanamide is formed by decomposition of 2-cyanoguanidine. Dicyanamide is used extensively as a counterion of organic and inorganic salts, as it is a "chemically inert, hydrophobic anion" and pseudohalide. It is also as a reactant for the synthesis of various covalent organic structures. Dicyanamide has a very low proton affinity, less than 310 ± 3 kcal·mol−1. Its gas-phase conjugate acid is iminomethylidenecyanamide HN=C=N−C≡N, which is predicted to be slightly more stable than the symmetric tautomer dicyanimide N≡C−NH−C≡N. Dicyanamide was used as an anionic component in an organic superconductor that was, when reported in 1990, a superconductor with the highest transition temperature in its structural class. Dean Kenyon examined the role of this chemical in reactions that can produce peptides, and a co-worker examined dicyanamide's possible role in primordial biogenesis.
Sources: en.wikipedia.org
Therapeutic Heparin (>15 units/kg/h) Platelet count <30,000/mm3 Recent (within 6 weeks) gastrointestinal bleeding Recent administration (within 3 days) of thrombolytic therapy Recent administration (within 7 days) of oral anticoagulants or GP IIb/IIIa inhibitors Recent administration (within 7 days) of >650 mg/day of aspirin or other platelet inhibitors Recent (within 3 months) ischemic stroke Known or suspected intracranial AV malformation or aneurysm Known bleeding diathesis (e.g., hemophilia) except for acute coagulopathy related to sepsis Chronic severe hepatic disease HIV infection in association with a last known CD4 count of <50/mm3 Any other condition in which bleeding constitutes a significant hazard or would be particularly difficult to manage because of its location Because drotrecogin-alpha is a therapeutic protein, there exists a potential for immunogenicity. Antibodies against drotrecogin have been observed. There is insufficient data at this time to quantify the risk, but extreme caution should be exercised if a patient has previously received drotrecogin-alpha.
Cameron introduced the referendum in order to fulfill a manifesto pledge, but campaigned on the side of the "remain" vote, along with most of the other major parties. Some members of the Conservatives, as well as the Democratic Unionist Party (DUP) and UK Independence Party (UKIP), campaigned to "leave." The "leave" vote unexpectedly won, and a few hours later Cameron announced he would resign. A leadership election was held and Cameron was succeeded by Theresa May. May became the UK's second female prime minister after Margaret Thatcher, as well as the first woman to hold two of the Great Offices of State. She began the process of withdrawing the UK from the European Union, triggering Article 50 in March 2017. The following month, she announced a snap general election, with the aims of strengthening her hand in Brexit negotiations and campaigning on "strong and stable" leadership. This election resulted in a hung parliament, in which the Conservatives actually losing seats, despite the party winning its highest vote share since 1983. The loss of an overall majority prompted her to enter a confidence and supply arrangement with the DUP of Northern Ireland to support a minority government. After versions of her draft withdrawal agreement were rejected by Parliament three times, she resigned in 2019 and was succeeded by Boris Johnson, her former Foreign Secretary. Following further defeats in Parliament, Johnson prorogued parliament, an act deemed illegal by the Supreme Court.
According to the Big Bang theory, stable isotopes of the lightest three elements (H, He, and traces of Li) were produced very shortly after the emergence of the universe, in a process called Big Bang nucleosynthesis. These lightest stable nuclides (including deuterium) survive to today, but any radioactive isotopes of the light elements produced in the Big Bang (such as tritium) have long since decayed. Isotopes of elements heavier than boron were not produced at all in the Big Bang, and these first five elements do not have any long-lived radioisotopes. Thus, all radioactive nuclei are, therefore, relatively young with respect to the birth of the universe, having formed later in various other types of nucleosynthesis in stars (in particular, supernovae), and also during ongoing interactions between stable isotopes and energetic particles. For example, carbon-14, a radioactive nuclide with a half-life of only 5700(30) years, is constantly produced in Earth's upper atmosphere due to interactions between cosmic rays and nitrogen. Nuclides that are produced by radioactive decay are called radiogenic nuclides, whether they themselves are stable or not. There exist stable radiogenic nuclides that were formed from short-lived extinct radionuclides in the early Solar System. The extra presence of these stable radiogenic nuclides (such as xenon-129 from extinct iodine-129) against the background of primordial stable nuclides can be inferred by various means.
Similarly, ethylene oxide is detected by the bright pink color of the indicator when passing air through aqueous solutions of some salts of sodium or potassium (chlorides, iodides, thiosulfates, etc.) with the addition of phenolphthalein:
Sources: en.wikipedia.org
=== Tuberculosis === The primary use of isoniazid is as first-line treatment for latent and active infection of Mycobacterium tuberculosis, the causative agent of tuberculosis (TB). In persons with isoniazid-resistant Mycobacterium tuberculosis infection, drug regimens based on isoniazid have a high rate of failure. In the United States, the indications for isoniazid use approved by the U.S. Food and Drug Administration (FDA) include:.
Blood levels necessary to cause adverse effects in adults are thought to be greater than about 150 ng/mL. An excess of vitamin D causes hypercalcaemia (high blood concentrations of calcium), which can cause overcalcification of the bones and soft tissues including arteries, heart, and kidneys. Untreated, this can lead to irreversible kidney failure. Symptoms of vitamin D toxicity may include the following: increased thirst, increased urination, nausea, vomiting, diarrhea, decreased appetite, irritability, constipation, fatigue, muscle weakness, and insomnia. In 2011, the US National Academy of Medicine revised tolerable upper intake levels (UL) to protect against vitamin D toxicity. Before the revision the UL for ages 9+ years was 50 μg/d (2000 IU/d). Per the revision: "UL is defined as "the highest average daily intake of a nutrient that is likely to pose no risk of adverse health effects for nearly all persons in the general population". The US ULs in micrograms (mcg or μg) and international units (IU) for both males and females, by age, are:
1st choice: Surgical amputation - break - prosthesis 2nd choice: Surgical amputation - transplantation of other tissue - plastic reconstruction. 3rd choice: Replantation - reconnection - revascularisation of amputated limb, by microscope (after 1969) 4th choice: Transplantation of cadaveric hand (after 2000)
=== Cryogenic refrigeration === The Topeka, Kansas shops of the Santa Fe Railway built five experimental refrigerator cars employing liquid nitrogen as the cooling agent in 1965. A mist induced by liquefied nitrogen was released throughout the car if the temperature rose above a pre-determined level. Each car carried 3,000 pounds (1,400 kg) of refrigerant and could maintain a temperature of minus 20 degrees Fahrenheit (−30 °C). During the 1990s, a few railcar manufacturers experimented with using liquid carbon dioxide (CO2) as a cooling agent. The move was in response to rising fuel costs and aimed to eliminate standard mechanical refrigeration systems that required periodic maintenance. The CO2 system can keep the cargo frozen solid for 14 to 16 days. Several hundred "cryogenic" refrigerator cars were placed in service to transport frozen foodstuffs. However, they failed to gain wide acceptance (due in part to the rising cost of liquid carbon dioxide).
==== Roll-to-roll ==== In 2014, a two-step roll-to-roll manufacturing process was announced. The first roll-to-roll step produces the graphene via chemical vapor deposition. The second step binds the graphene to a substrate.
Sources: en.wikipedia.org
It is usually classified as an immunomodulatory peptide rather than a classical hormone. It derives from the larger protein prothymosin alpha and acts mainly on immune cells. The thymosin label covers a group of distinct peptides, so the naming can be misleading.
The two share a family name but have different sequences, sizes, and functions. Thymosin beta-4 is a 43-residue peptide associated with actin binding and cell migration. Thymosin alpha-1 is a 28-residue peptide linked mainly to immune signaling.
Thymalfasin is the assigned international nonproprietary name for the synthetic 28-residue peptide. Thymosin alpha-1 is the descriptive research name for the same molecule. Which term appears depends on the context and the regulatory document.
Reverse-phase HPLC with ultraviolet detection at 214 nm is common. Mass spectrometry is used to confirm molecular identity and detect modifications. Immunoassays exist but may not distinguish the intact peptide from fragments.